**Core Concept**
Alglucerase is a recombinant form of the enzyme glucocerebrosidase, which plays a crucial role in the breakdown of glucocerebroside in the lysosomes of cells. Gaucher's disease is a genetic disorder characterized by the accumulation of glucocerebroside due to a deficiency of this enzyme.

**Why the Correct Answer is Right**
In Gaucher's disease, the deficiency of glucocerebrosidase leads to the accumulation of glucocerebroside in various organs, including the spleen, liver, and bone marrow. Alglucerase works by replacing the deficient enzyme, thereby facilitating the breakdown of glucocerebroside and reducing its accumulation in the body. This treatment approach is an example of enzyme replacement therapy (ERT), a strategy used to manage various lysosomal storage disorders.

**Why Each Wrong Option is Incorrect**
**Option B:** Galactosemia is a genetic disorder caused by a deficiency of the enzyme galactose-1-phosphate uridyltransferase, which is involved in the metabolism of galactose. Alglucerase is not used to treat galactosemia.
**Option C:** Niemann-Pick disease is a group of genetic disorders caused by a deficiency of the enzyme sphingomyelinase, which is involved in the breakdown of sphingomyelin. Alglucerase is not used to treat Niemann-Pick disease.
**Option D:** Pompe's disease is a genetic disorder caused by a deficiency of the enzyme acid alpha-glucosidase, which is involved in the breakdown of glycogen. Alglucerase is not used to treat Pompe's disease.

**Clinical Pearl / High-Yield Fact**
Gaucher's disease is an autosomal recessive disorder, meaning that a person must inherit two defective copies of the gene (one from each parent) to develop the disease. Enzyme replacement therapy, like alglucerase, has revolutionized the management of Gaucher's disease, improving the quality of life for affected individuals.

**✓ Correct Answer: A. Gaucher's disease**